EISAI INC. lobbying for EISAI INC.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Expenses

$790,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 7

S 2658
Medication Affordability and Patent Integrity Act
HR 6130
ASAP Act
S 3267
ASAP Act
HR 4752
Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023
S 2379
CHANGE Act of 2023
HR 3747
Accelerating Access to Dementia and Alzheimer’s Provider Training Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 6

Trade (domestic/foreign)

Supply chain manufacturing and tariffs, including: the Section 232 and Section 301 tariff investigations related to branded pharmaceuticals.

Copyright/Patent/Trademark

Pharmaceutical Intellectual Property (IP), including: S. 2658, Medication Affordability and Patent Integrity Act.

Manufacturing

Pharmaceutical manufacturing.

Health Issues

Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; Pharmacy Benefit Manager (PBM) reform, 340B Drug Discount Program.

Medicare/Medicaid

General Medicare and Medicaid including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; Center for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers Screening and Prevention (ASAP) Act; H.R. 4752 / S. 2379, the Concentrating on High-value Alzheimers Needs to Get to an End (CHANGE) Act; H.R. 3747, the Accelerating Access to Dementia and Alzheimers Provider Training (AADAPT) Act

Taxation/Internal Revenue Code

Tax reform, including: H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.